Solifenacin (Bispec (5 mg)) is a urinary antispasmodic agent, prescribed for overactive bladder with or without incontinence.It works by blocking the action of certain chemicals in the body to help ...
TOKYO, May 7, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has approved ...
With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Advisory Alert: It has come to our attention ...
Shares of pharma major Glenmark Pharma rose as much as 2.5 percent intraday Thursday as it has received tentative USFDA nod for Solifenacin Succinate tablets. "Glenmark Pharmaceuticals Inc., USA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback